Integrated care

Despite national efforts to facilitate transitions of care and improve interaction between providers, health systems remain fragmented when delivering care. Recent OECD work flags how poor integration undermines the full potential of health care (OECD, 2020[14]). This is especially true for those who transition between care settings with complex health conditions, such as mental illness (OECD, 2021[39]). Poor co-ordination is also reported between health, long-term and social care (OECD, 2020[56]). These failures have been magnified by the COVID-19 pandemic, with fragmented care between hospitals and community care damaging continuity of care and risking the delivery of safe care for the most vulnerable populations (OECD, 2020[57]).

Integrated care can improve patient outcomes and experiences. It also increases value for money by improving co-ordination, while reducing duplicative and unnecessary care. OECD work has identified key mechanisms for improving integrated care: strengthening governance, developing strong information systems, building a skilled workforce and ensuring aligned financial incentives (OECD, 2017[17]).

Indicators such as mortality, readmissions and medication prescriptions after hospitalisation provide insight into the quality of integration between hospital and community care. Stroke and CHF indicators in the year following discharge can be calculated using patient-level hospital records linked to death registries and outpatient prescribing data. However, only three OECD countries (Czech Republic, Finland and Sweden) participating in the OECD pilot data collection on Integrated Care are presently able to link all the data sources for reporting prescription indicators, in addition to all the other indicators.

Figure 6.38 shows the mortality and readmissions outcomes across OECD countries in the year after discharge following ischaemic stroke or CHF in 2018. For patients who suffered an ischaemic stroke, on average, 64% survived and did not return to acute care, 22% survived and were readmitted to hospital (4% for stroke-related and 18% for other reasons) and 14% died in the following year. For CHF patients, on average, 45% who survived did not return to acute care, while 32% survived but were readmitted for CHF related or other causes and 23% died in the following year.

For patients who suffered a stroke and were discharged, 1-year mortality ranged from 2% in Japan to 25% in Estonia. For CHF patients, 1-year mortality varied from 8% in Japan to 33% in Slovenia. 1-year readmissions of stroke patients surviving one year or more ranged from 1% in Lithuania to 6% in Norway for stroke-related reasons, and from 0% in Costa Rica to 28% in the Czech Republic for non-stroke causes. For patients with CHF surviving one year or more, readmission rates varied from 1% in Italy to 17% in Israel for CHF-related causes and from 0% in Costa Rica to 29% in the Czech Republic for other causes.

Trend analysis can identify changes over time, such as improvements in mortality and readmission rates. Data for 2013-18 are shown for the percentage of discharged stroke and CHF patients readmitted or dying in the year following discharge either for any cause (Figure 6.39) or for the primary diagnosis (Figure 6.40). Most countries demonstrated small improvements over a five-year period. Costa Rica, Sweden and Israel demonstrated the largest improvements for reducing 1-year readmissions and mortality following an ischaemic stroke, and Costa Rica, Sweden, Japan and Israel for CHF. Similar declines can be seen for 30-day case fatality rates for ischaemic stroke (see indicator “Mortality following ischaemic stroke”). However, some countries reported worsening rates, including Lithuania, Norway and Finland.

Variation in outcomes across countries can be partly explained by differences in the organisation of care delivery, and differences in access to care, payment mechanisms and information systems. For example, Estonia adopted a new person-centred care network model and Finland defined a new governance model of financing, organisation and information to drive integration of health and social care.

Metadata, Legal and Rights

This document, as well as any data and map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area. Extracts from publications may be subject to additional disclaimers, which are set out in the complete version of the publication, available at the link provided.

© OECD 2021

The use of this work, whether digital or print, is governed by the Terms and Conditions to be found at